Remission of a refractory nephrotic syndrome after low-density lipoprotein apheresis based on dextrane sulphate adsorption.
Faucher
C
C
Service de Néphrologie, Centre Hospitalier Général de Chartres, France.
Albert
C
C
Beaufils
H
H
Jouanneau
C
C
Dupouet
L
L
D000327:Adsorption; D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects; D001781:Blood Component Removal / Q000379:methods*; D002784:Cholesterol / Q000097:blood / Q000302:isolation & purification; D016264:Dextran Sulfate; D006801:Humans; D008077:Lipoproteins, LDL / Q000097:blood / Q000302:isolation & purification*; D008297:Male; D009404:Nephrotic Syndrome / Q000097:blood / Q000209:etiology / Q000628:therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D012460:Sulfasalazine / Q000009:adverse effects; D014280:Triglycerides / Q000097:blood / Q000302:isolation & purification
D018501:Antirheumatic Agents; D008077:Lipoproteins, LDL; D014280:Triglycerides; D012460:Sulfasalazine; D016264:Dextran Sulfate; D002784:Cholesterol